Post by Advanced Electrophoresis Solutions Ltd. (AES)

We are pleased to share that our collaborative work with biopharma industry colleagues, published in ELECTROPHORESIS, is among the journal's top 10 most-cited papers of 2024. The study highlights the use of icIEF-MS for the characterization of cysteine-linked Antibody-Drug Conjugate (ADC) heterogeneity under native conditions. The full paper is available for download at the link below: https://lnkd.in/em7CVMkB This milestone highlights the growing impact of icIEF-HRMS in the biopharma industry, particularly for its ability to characterize complex Cysteine-Linked Antibody-Drug Conjugates (ADCs) under native conditions. 📩 Interested in accelerating your charge variant programs? Please connect with us at [email protected]. Let’s move your science forward—together.